These results support the idea that human mutations in CELSR3 may contribute to TD not through gross structural abnormalities or interneuron loss, but by impairing the integration and signaling capacity of cortical neurons and/or interneurons within critical CSTC circuits. This evidence concerns the gene CELSR3 and thanatophoric dysplasia.